Search

Bertram Eichel Phones & Addresses

  • 30 Ashmont Dr, Framingham, MA 01701 (508) 877-1884
  • 9 Millbury St, Grafton, MA 01519 (508) 839-6402
  • E Falmouth, MA
  • E Falmouth, MA

Professional Records

License Records

Bertram Eichel

Address:
Grafton, MA 01519
License #:
DN12497 - Expired
Category:
DENTISTRY
Issued Date:
Apr 20, 1974
Renew Date:
Mar 31, 2006
Expiration Date:
Mar 31, 2006
Type:
Dentist

Publications

Us Patents

Process And Apparatus For The Removal Of Toxic Components Of Tobacco Smoke And The Standardization Of The Health Hazards Related To Those Components

View page
US Patent:
6796312, Sep 28, 2004
Filed:
Aug 30, 2001
Appl. No.:
09/943144
Inventors:
Bertram Eichel - Framingham MA, 01701
International Classification:
A24B 1518
US Classification:
131334, 131332, 131207, 131202, 131331
Abstract:
The oral cavity is a source of sensitive biomarkers that allow the development of novel tobacco filters to reverse and eliminate acute adverse effects of tobacco smoke. Useful biomarkers are ubiquitous functional leukocytes and associated essential biochemical mechanisms, including metabolic pathways and specific enzymes, such as myeloperoxidase contained in fluid-cell lavages obtained from the human mouth. These biomarkers derived from the human mouth and sputum from the human respiratory system can be used to evaluate long-term chronic effects of tobacco smoke. A tobacco filter comprising strongly basic anion exchange resins and strongly acidic cation exchange resins with or without activated carbon, is used to detect, reduce and eliminate toxic substances from tobacco smoke while retaining taste and aroma. The novel filter in conjunction with biomarkers allow the establishment of performance standards that permit the direct visualization and measurement of acute adverse reactions caused by tobacco smoke. The measurement of these adverse effects allow a human health hazard reduction scale to be created to inform smokers of the relative âsafetyâ of any smoking product.

Process And Apparatus For The Removal Of Toxic Components Of Tobacco Smoke And The Standardization Of The Health Hazards Related To Those Components

View page
US Patent:
20050005946, Jan 13, 2005
Filed:
May 12, 2004
Appl. No.:
10/844254
Inventors:
Bertram Eichel - Framingham MA, US
International Classification:
A24D001/04
US Classification:
131334000, 131331000
Abstract:
The oral cavity is a source of sensitive biomarkers that allow the development of novel tobacco filters to reverse and eliminate acute adverse effects of tobacco smoke. Useful biomarkers are ubiquitous functional leukocytes and associated essential biochemical mechanisms, including metabolic pathways and specific enzymes, such as myeloperoxidase contained in fluid-cell lavages obtained from the human mouth. These biomarkers derived from the human mouth and sputum from the human respiratory system can be used to evaluate long-term chronic effects of tobacco smoke. A tobacco filter comprising strongly basic anion exchange resins and strongly acidic cation exchange resins with or without activated carbon, is used to detect, reduce and eliminate toxic substances from tobacco smoke while retaining taste and aroma. The novel filter in conjunction with biomarkers allow the establishment of performance standards that permit the direct visualization and measurement of acute adverse reactions caused by tobacco smoke. The measurement of these adverse effects allow a human health hazard reduction scale to be created to inform smokers of the relative “safety” of any smoking product.

Novel Compositions For Establishing Environmental Conditions Favorable To Oral Leucocytes

View page
US Patent:
40242374, May 17, 1977
Filed:
Aug 4, 1975
Appl. No.:
5/601849
Inventors:
Bertram Eichel - Framingham MA
Vincent F. Lisanti - North Bergen NJ
International Classification:
A61K 716
A61K 720
A61K 724
US Classification:
424 49
Abstract:
Novel compositions for establishing environmental conditions in the human oral cavity for maintaining healthy, functional oral leucocytes, said compositions comprising a non-toxic mixture of effective amounts of: (1) at least one compound for maintaining a colloidal and viscous environment within the oral cavity which favors and promotes oral leucocyte locomotion, phagocytosis and bacterial kill; (2) at least one compound providing and maintaining a balanced ionic environment which favors and promotes locomotion, phagocytosis and bacterial kill; (3) at least one compound providing a source of energy for said oral leucocytes; and (4) at least one compound for maintaining substantially a physiological pH to promote leucocyte functions while avoiding other tissue and cell injury; and novel products and processes employing the same.
Bertram A Eichel from Framingham, MADeceased Get Report